Literature DB >> 22070749

Examining the relationship between risk assessment and risk management in mental health.

E Gilbert1, A Adams, C D Buckingham.   

Abstract

Thorough risk assessment helps in developing risk management plans that minimize risks that can impede mental health patients' recovery. Department of Health policy states that risk assessments and risk management plans should be inextricably linked. This paper examines their content and linkage within one Trust. Four inpatient wards for working age adults (18-65 years) in a large mental health Trust in England were included in the study. Completed risk assessment forms, for all patients in each inpatient ward were examined (n= 43), followed by an examination of notes for the same patients. Semi-structured interviews took place with ward nurses (n= 17). Findings show much variability in the amount and detail of risk information collected by nurses, which may be distributed in several places. Gaps in the risk assessment and risk management process are evident, and a disassociation between risk information and risk management plans is often present. Risk information should have a single location so that it can be easily found and updated. Overall, a more integrated approach to risk assessment and management is required, to help patients receive timely and appropriate interventions that can reduce risks such as suicide or harm to others.
© 2011 Blackwell Publishing.

Entities:  

Mesh:

Year:  2011        PMID: 22070749     DOI: 10.1111/j.1365-2850.2011.01737.x

Source DB:  PubMed          Journal:  J Psychiatr Ment Health Nurs        ISSN: 1351-0126            Impact factor:   2.952


  2 in total

1.  Involving carers in risk assessment: a study of a structured dialogue between mental health nurses and carers.

Authors:  Haley Jackson; Jane Wray; Eric Gardiner; Tracy Flanagan
Journal:  J Res Nurs       Date:  2019-08-08

Review 2.  Patient Safety Strategies in Psychiatry and How They Construct the Notion of Preventable Harm: A Scoping Review.

Authors:  Jakob Svensson
Journal:  J Patient Saf       Date:  2022-04-01       Impact factor: 2.243

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.